Abstract:Background: Hepatocellular carcinoma (HCC) is characterized by considerable phenotypic and molecular heterogeneity, but the overall survival of HCC patients remains extremely poor. Thus, novel and efficient alternatives to antitumor agents are urgently needed. Pectolinarigenin, a flavonoid compound extract, has been previously reported for the treatment of nasopharyngeal cancer. However, the potential antitumor roles of pectolinarigenin in HCC have not been clearly elaborated. In the present study, we investigated its role in HCC treatment and explored the potential molecular mechanism(s). Materials and methods: HCC cell lines SMMC7721 and PLC5 were cultured and treated with indicated concentrations of pectolinarigenin. For the HCC cell proliferation, after HCC cells were stimulated with indicated concentrations of pectolinarigenin, the cell viability was detected in CCK-8 and colony-forming assays. HCC cell invasion/migration assay was performed by Transwell and wound scratch methods. Additionally, cellular apoptosis and cell cycle arrest analysis was performed with flow cytometric analysis. Finally, the involved underlying signaling pathway, the PI3K/AKT/mTOR/ERK signaling-related molecular markers were detected through Western blot methods with indicated antibodies. Meanwhile, antitumor activity of pectolinarigenin was also assessed in tumor-bearing mice. Results: The results indicated that the treatment with pectolinarigenin significantly inhibited cell proliferation and migratory and invasive abilities of SMMC7721 and PLC5 cells in concentration- and time-dependent manner. Meanwhile, pectolinarigenin markedly induced cell apoptosis and G2/M phase arrest in SMMC7721 and PLC5 cells, which was associated with apoptosis- and cell cycle-related protein levels, respectively. Furthermore, pectolinarigenin inhibited PI3K/AKT/mTOR/ERK signaling pathway. It also significantly suppressed HCC tumor growth in vivo. Conclusion: Pectolinarigenin could suppress the viability and motility and cause apoptosis and G2/M phase arrest in HCC cell lines by inhibiting the PI3K/AKT/mTOR/ERK signaling pathway. This might be an appealing potential therapeutic agent for HCC treatment.

Anti-hepatocarcinoma Effects of Puerarin-Nanoethosomes Against Human HepG2 Cells

Evaluation of Anti-Hepatocarcinoma Capacity of Puerarin Nanosuspensions Against Human Hepg2 Cells

<i>In </i><i>Vitro</i> Antitumor Efficacy of Puerarin Nanosuspension against Human HepG2 Cells

Natural product pectolinarigenin inhibits proliferation, induces apoptosis, and causes G2/M phase arrest of HCC via PI3K/AKT/mTOR/ERK signaling pathway.

Anti-hepatocarcinoma Effects of Berberine-Nanostructured Lipid Carriers Against Human HepG2, Huh7, and EC9706 Cancer Cell Lines

Anti-Hepatocarcinoma Effects of Berberine Nanosuspension Against Human Hepg2 and Huh7 Cells As Well As H22 Tumor Bearing Mice

Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition

In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity

Puerarin Increases the Chemosensitivity of Hepatocellular Carcinoma Cells.

Puerarin: a hepatoprotective drug from bench to bedside

Synthesis, Characterization, and Formulation of Poly-Puerarin As a Biodegradable and Biosafe Drug Delivery Platform for Anti-Cancer Therapy

Synergistic effect of puerarin and 5-fluorouracil on hepatocellular carcinoma.

In Vitro Antitumor Efficacy of Berberine: Solid Lipid Nanoparticles Against Human HepG2, Huh7 and EC9706 Cancer Cell Lines

Puerarin Inhibits Bladder Cancer Cell Proliferation Through the Mtor/p70s6k Signaling Pathway.

In Vitro and in Vivo Antitumor Efficacy of Berberine-Nanostructured Lipid Carriers Against H22 Tumor

Nano-puerarin Regulates Tumor Microenvironment and Facilitates Chemo- and Immunotherapy in Murine Triple Negative Breast Cancer Model

Anti-Hepatocarcinoma Effects of Resveratrol Loaded Solid Nanodispersion by A New Material Nano Silica

Polymeric micelles loading with ursolic acid enhancing anti-tumor effect on hepatocellular carcinoma

Study on Anti-Hepatocarcinoma Activity of Tectorigenin from Pueraria Flos in Vitro

Inhibitory Efficacy of the Quantified Prunellae Spica Extract on H22 Tumor Bearing Mice

The Isoflavone Puerarin Exerts Anti-Tumor Activitiy in Pancreatic Ductal Adenocarcinoma by Suppressing Akt/mTOR Activity